News and Events
Galt Pharmaceuticals Answers the Call for Better Practices in Pain Management with a Non-opioid Therapeutic Alternative
May 29, 2019
Officials with the FDA have given Priority Review designation to an opioid-free pain management treatment from Galt Pharmaceuticals.
According to the company, its Supplemental Abbreviated New Drug Application for the orphenadrine citrate, aspirin and caffeine combination (Orphengesic Forte), a muscle relaxant pain reliever, was given ...
Innovative Pharma Company Galt Signs 50th Franchise
February 14, 2019
ATLANTA--(BUSINESS WIRE)--The first and only pharmaceutical company to create a unique franchise pharma concept referred to as “phranchising,” Galt Pharmaceuticals recently signed its 50th territory.
“Our unique model offers the right entrepreneur the opportunity to run their own pharmaceutical company in their local market using a very patient-centric approach to educating healthcare providers,” said Galt CEO and co-founder Barry Patel, Pharm.D.
Validating this transformative model, Atlanta-based Galt brought on ...
Galt Pharmaceuticals Will Be Exhibiting at the PDS (Pharmacy-Owners) Conference in Orlando Florida
Dates: February 21st - 23rd, 2019
If you are attending the conference please stop-by our exhibit booth 808 and contact us at firstname.lastname@example.org if you’d like to set up a time to meet to discuss phranchise opportunities.